Pancreatic Disorders News

Infection with SARS-CoV-2 increased the risk for long-term gastrointestinal problems within 1 year, including motility disorders, acute pancreatitis and liver disease, according to a study published in Nature Communications.

Receipt of perichemotherapy antibiotics correlated with improved survival in patients with metastatic pancreatic ductal adenocarcinoma treated with gemcitabine, but not fluorouracil, according to results in JAMA Network Open.

A machine learning model may aid the detection and classification of tertiary lymphoid structures associated with gastrointestinal cancers based on routine tissue slides, according to research in JAMA Network Open.

The incidence of pancreatic cancer increased at a faster rate over time among women aged younger than 55 years compared with their male counterparts, according to research published in Gastroenterology.

The FDA has granted fast track designation for olezarsen in the treatment of familial chylomicronemia syndrome, according to a press release from Ionis Pharmaceuticals.

Infection, cardiovascular disease, narcotic dependence and other psychosocial issues were among causes linked to reduced 10-year survival in patients who underwent surgical intervention for chronic pancreatitis, researchers reported.

CHARLOTTE, N.C. — Pancreatic cancer screenings in high-risk individuals identified high-risk lesions in nearly 1% of patients and intermediate-risk pathology in more than 30%, according to data presented at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Tobacco use, type 2 diabetes and advanced chronic kidney disease increased the risk for acute pancreatitis after initiation of glucagon-like peptide-1 receptor agonists for weight loss, noted a presenter at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Pancreatic duct disruption and disconnection were associated with increased short- and long-term complications in patients with necrotizing pancreatitis, according to data presented at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Type 3 autoimmune pancreatitis led to rapid pancreatic atrophy and functional endocrine failure despite steroid therapy or immune checkpoint inhibitor withdrawal, a researcher reported at ACG Annual Scientific Meeting.